Summit Trail Advisors, LLC Fibrogen Inc Transaction History

Summit Trail Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$56.3 - $67.25 $54,216 - $64,761	-963 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$44.9 - $64.95 $2.02 Million - $2.92 Million	-45,032 Reduced 97.91%	963 $60,000
Q1 2018 May 21, 2018	BUY	$45.35 - $61.65 $2.03 Million - $2.76 Million	44,846 Added 3903.05%	45,995 $46,000
Q4 2017 Feb 14, 2018	BUY	$41.95 - $60.1 $48,200 - $69,054	1,149	1,149 $58,000

47.2M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $58.1M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.